Denosumab in Patients With Fibrous Dysplasia Previously Treated With Bisphosphonates
Denosumab in Patients With Fibrous Dysplasia Previously Treated With Bisphosphonates [...]
About admin
This author has not yet filled in any details.So far admin has created 239 blog entries.
Meeting report from the achondroplasia foramen magnum workshop, Salzburg, Austria 22nd June 2019
Meeting report from the achondroplasia foramen magnum workshop, Salzburg, Austria [...]
Animal models to explore the effects of glucocorticoids on skeletal growth and structure
Animal models to explore the effects of glucocorticoids on skeletal [...]
Elucidating the genetic architecture of Adams-Oliver syndrome in a large European cohort
Elucidating the genetic architecture of Adams-Oliver syndrome in a large [...]
Increased Risk of Breast Cancer at a Young Age in Women with Fibrous Dysplasia
Increased Risk of Breast Cancer at a Young Age in [...]
Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases
Early clinical observations on the use of imatinib mesylate in [...]
Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature
Clinical relevance of systematic phenotyping and exome sequencing in patients [...]
Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework
Assessing the gene-disease association of 19 genes with the RASopathies [...]
ClinGen RASopathy Working Group. ClinGen’s RASopathy Expert Panel consensus methods for variant interpretation
ClinGen RASopathy Working Group. ClinGen's RASopathy Expert Panel consensus methods [...]
Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments
Validation of a novel, rapid, high precision sclerostin assay not [...]
Funded by the European Union
“Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.”
